Stock IOLCP IOL CHEMICALS AND PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages IOL Chemicals and Pharmaceuticals Limited NSE India S.E.

Equities

IOLCP

INE485C01011

Market Closed - NSE India S.E.
Other stock markets
 05:17:54 21/06/2024 pm IST 		5-day change 1st Jan Change
415.8 INR -1.16% Intraday chart for IOL Chemicals and Pharmaceuticals Limited +1.68% -10.25%
16/05 Transcript : IOL Chemicals and Pharmaceuticals Limited, Q4 2024 Earnings Call, May 16, 2024
19/03 IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units MT

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units
IOL Chemicals Gets Nod to Export Diabetes Drug to China
IOL Chemicals and Pharmaceuticals Limited Announces CDE, China Approved Metformin Hydrochloride
IOL Chemicals and Pharmaceuticals Limited Approves Closing of M/S Iol Global Limited, Uk, Wholly Owned Subsidiary of the Company
IOL Chemicals and Pharmaceuticals Limited Declares Interim Dividend for the Financial Year 2023-24
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
IOL Chemicals and Pharmaceuticals Receives Cep for Paracetamol to Export in European Market
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
IOL Chemicals and Pharmaceuticals Appoints Vikas Vij as CEO
IOL Chemicals and Pharmaceuticals Limited Announces Resignation of Sanjay Chaturvedi as CEO
IOL Chemicals and Pharmaceuticals Limited Declares Interim Dividend for the Fiscal Year 2023, Payable Before 8 March 2023
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
IOL Chemicals and Pharmaceuticals Limited Intimates Incorporation of Wholly Owned Subsidiary
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
IOL Chemicals and Pharmaceuticals Limited Receives EDQM Certification to Supply Pantoprazole Sodium Sesquihydrate API in European Market
IOL Chemicals and Pharmaceuticals Limited Approves Setting Up of New Plant for Speciality Chemicals and Pharmaceuticals Intermediates in Western India
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IOLCP Stock
  4. IOLCP Stock
  5. News IOL Chemicals and Pharmaceuticals Limited
  6. Other languages